Term
Acetylcholinesterase inhibitors |
|
Definition
- they aren't parasympathomimetics
- can mimic the effects of parasympathetic stimulation and other kinds of stimulation too- they produce skeletal muscle contractility as a potential effect, as well as CNS effects |
|
|
Term
|
Definition
- group of agents which, for the most part, are either muscarinic agonists or indirect-acting parasympathomimetics
- agent that mimics the effects of parasympathetic stimulation
|
|
|
Term
|
Definition
- mimic the effects of acetylcholine (Ach)
- Ach acts at a bunch of places; it has nicotinic or muscarinic effects
- we use parasympathomimetic instead of cholinomimetic
|
|
|
Term
|
Definition
- parasympathomimetic, but they can ALSO mimic the effects of sympathetic stimulation,
**ex. a muscarinic agonist will produce an increase in sweating, and that's mediated by a sympathetic cholinergic nerve
|
|
|
Term
Indirect-acting Parasympathomimetics |
|
Definition
- carbachol; at its lowest doses it produces indirect parasympathomimetic-like effects
|
|
|
Term
Acetylcholinesterase (AchE) Inhibitors |
|
Definition
- can increase Ach levels;
(Ach acts as a neurotransmitter at the
neuroeffector junction between cholinergic
nerves and muscarinic receptors)
- they can also produce nicotinic effects, because Ach acts at different places
|
|
|
Term
|
Definition
-parasympathomimetics
- AchE inhibitors
- depolarizing neuromuscular blockers
|
|
|
Term
|
Definition
depolarizing neuromuscular blocker |
|
|
Term
In Vivo Diagnostics
(parasympathomimetics)
|
|
Definition
- methacholine can produce contraction of bronchial smooth muscle
- one can diagnose for pulmonary hyper-reactivity by administering increasing doses (concentrations) of agents, including methacholine
- people who have hyper-reactivity of the respiratory tract will develop a contractile response at very low doses in the inspired air; this can be alleviated by giving a beta-2 agonist
|
|
|
Term
|
Definition
Nicotine
Pilocarpine
Muscarine
Arecholine |
|
|
Term
|
Definition
- it is the prototype nicotinic receptor agonist
- it also produces an inactivation of the nicotinic receptor on continual stimulation
- it is a natural cholinomimetic
|
|
|
Term
|
Definition
- muscarinic agonist; acts on muscarinic receptors; has affinity and intrinsic activity,
- it is still used
|
|
|
Term
|
Definition
- found in mushrooms
- it's able to stimulate muscarinic receptors
|
|
|
Term
|
Definition
- naturally occurring cholinomimetic
- found in beetle nut
- it mimics the effects of cholinergic stimulation
and has muscarinic agonist activity;
- not used at present |
|
|
Term
Indirect-acting parasympathomimetics
|
|
Definition
|
|
Term
|
Definition
- also known as Reglan
- acts as an indirect-acting parasympathomimetic;
- it promotes the release of Ach from cholinergic post-ganglionic nerve terminal endings
|
|
|
Term
|
Definition
Methacholine- synthetic choline ester
Bethanecol- synthetic choline ester
Cevimeline- synthetic muscarinic agonist
Pilocarpine- naturally-occurring muscarinic agonist
|
|
|
Term
|
Definition
- not first choice of drug, because:
1. lacks selectivity, it acts at all
cholinergic receptors
2. it's broken down very quickly by AchE
Naturally occurring, non-selective action
|
|
|
Term
Uses for Parasympathomimetics
|
|
Definition
- narrow-angle glaucoma
- urinary Retention
- GERD
- Sjogren's Syndrome
- In Vivo Diagnostics
|
|
|
Term
|
Definition
- Methacholine
- Carbachol
- Bethanechol |
|
|
Term
Cholinesterase Susceptibility |
|
Definition
- Ach is MOST susceptible to AchE (3+)
- methacholine is susceptible to
AchE to a degree (1+)
- carbachol and bethanecol are not broken
down by AchE, but the effect of carbachol can be influenced by cholinesterase
|
|
|
Term
|
Definition
- the effects of carbachol can be influenced by cholinesterase; it depends on release of Ach at low doses, so even though carbachol itself is not broken down by AchE, an AchE inhibitor could potentiate the effects of low-dose carbachol because it acts to promote the release of Ach, which itself is susceptible to AchE
|
|
|
Term
|
Definition
- has very prominent cardiovascular effects!!!
- it's rarely used systemically due to
cardiovascular receptor affinity
- Ach is 2+ for cardiovascular, but methacholine is much more potent because methacholine is not broken down as readily as Ach
|
|
|
Term
|
Definition
|
|
Term
|
Definition
- competitive muscarinic receptor antagonist;
- it antagonizes the effects of Ach on
muscarinic receptors, as well as
methacholine on muscarinic receptors
- carbachol has nicotinic effects as well as muscarinic effects, so it is not very
well-antagonized by atropine
- bethanechol and cevimeline are
antagonized by atropine;
|
|
|
Term
Metoclopramide and bethanechol |
|
Definition
- used in GERD to increase the lower esophageal sphincter tone; they also promote emptying of stomach |
|
|
Term
|
Definition
- increase in intraocular fluid pressure
- can be genetic, NOT reversible!
- glucocorticoids increase your risk for glaucoma
- the continued elevation of IO fluid results in damage to the optic nerve; vision loss
- occurs very gradually
|
|
|
Term
Glaucoma & how drugs work here |
|
Definition
- the IO fluid goes through Canal of Schlemm
- some of the drugs used in glaucoma act by producing contraction of the pupillary sphincter, and as a consequence relieve the blockage of the Canal of Schlemm (narrow-angle glaucoma)
- some agents act by causing a decrease in the production of aqueous humor, decrese IOP
- parasympathomimetics, sympathomimetics
and prostaglandin derivatives are used
|
|
|
Term
ANS Drug Mechanisms in Glaucoma |
|
Definition
1. increase aqueous humor drainage
2. decrease aqueous humor formation
|
|
|
Term
Increase aqueous humor drainage |
|
Definition
-pilocarpine and carbachol
- can use parasympathomimetics, as they cause contraction of the sphincter muscle, or AchE inhibitors, as they increase the levels of Ach (also causing contraction of the sphincter muscle); these are called miotics, because they produce miosis
|
|
|
Term
Decrease aqueous humor formation |
|
Definition
- carbonic anhydrase inhibitors, and
prostaglandin derivatives
alpha-1 agonists- act on cilliary vessels
alpha-2 agonists- act on the cilliary body
beta-1 antagonists- act on the cilliary body to reduce aqueous humor formation
|
|
|
Term
Pilocarpine and carbachol |
|
Definition
Increase aqueous humor drainage
or "improve uveoscleral outflow"
- used topically because they can produce effects at other muscarinic receptors if used systemically
- they increase parasympathetic stimulation
|
|
|
Term
Bethanechol and carbachol |
|
Definition
- used in urinary retention as they increase
activity of the detrusor muscle
- they can produce effects wherever there are muscarinic receptors (or for carbachol, a cholinergic nerve); not preferred agents
- bethanechol is preferred over carbachol
|
|
|
Term
|
Definition
- Ach is used as a miotic for surgery
- it's administered into the eye, where it produces miosis for surgical procedures of the eye
- can't be used systemically as it has
non-selective effects
|
|
|
Term
|
Definition
B-2 agonist for bronchoconstriction reversal |
|
|
Term
Pilocarpine and cevimeline |
|
Definition
- used to combat xerostomia
- Pilocarpine is used as topical drops in the
mouth to promote salivation
- Cevimeline is an agent which is used specifically in Sjogren's; it increases the exocrine grandular secretions
|
|
|
Term
|
Definition
- these agents are used orally and/or topically;
NOT IV or SC because they will work at
all muscarinic receptors;
- bethanechol has a very high GI propensity, but it will produce bradycardia if it gets systemically
|
|
|
Term
|
Definition
- miotics (AchE inhibitors) may cause bronchoconstriction, so don't use in asthma!
- parasympathomimetics can worsen
the symptoms of angina, as they cause bradycardia
- do NOT be use in peptic ulcers
|
|
|
Term
|
Definition
- a muscarinic agonist or AchE inhibitor will cause an increase in contractility of the pupil, so you get miosis AND accomodation for near vision;
- muscarinic agonists can cause visual blurring
and impaired depth perception
- you won't be able to dilate your pupils, so it's difficult to drive at night;
|
|
|
Term
|
Definition
- parasympathetic stimulation causes
bradycardia, (a/v block);
- people who take beta-blockers have unopposed parasympathetic stimulation of the heart, and so giving a muscarinic agonist or a parasympathomimetic will increase the slowing of the heart because you have beta-blockade and less sympathetic stimulation, (which is producing the opposite effect of parasympathetic stimulation)
- people taking beta-blockers will have a
greater likelihood of developing cardiac
conduction disturbances***
|
|
|
Term
|
Definition
- is broken down by CYP2D6, so people who have
deficiencies in this enzyme will be very sensitive
to the effects of cevimeline |
|
|
Term
Muscarinic Receptor Antagonists |
|
Definition
- block the effects of Ach
- block the effects of muscarinic agonists
- can produce CNS effects if they can get there
|
|
|
Term
|
Definition
- prototype muscarinic receptor antagonists
- able to get into CNS, as well as periphery
- "belladonna alkaloids", naturally occurring muscarinic receptor antagonists
|
|
|
Term
|
Definition
- has atropine-like effects
- can get into CNS, and unlike atropine,
it can produce sedation; used in
preparation for surgery as
(1) enhances the effects of the general anesthetic
(2) combats some side-effects of GA
(excessive salivation, broncho-secretions)
- it blocks muscarinic receptors,
- can also combat motion sickness
but causes dry mouth
|
|
|
Term
|
Definition
- belladonna alkaloid like atropine
- effects are comparable to atropine
- does not produce sedation like scopolamine
|
|
|
Term
|
Definition
- not a belladonna alkaloid
- it is a synthetic muscarinic receptor antagonist
|
|
|
Term
|
Definition
- drugs that can block the effects of Ach; 2 kinds:
1. drugs that can get into CNS and block Ach receptors in CNS= anticholinergics
2. drugs which have antagonistic activity toward muscarinic AND nicotinic receptors; these are antagonists at cholinergic receptors
|
|
|
Term
CNS-acting anticholinergics |
|
Definition
- used in combatting diseases like Parkinsons;
- will still have peripheral muscarinic side-effects and precautions associated with peripherally-acting muscarinic antagonists |
|
|
Term
Quaternary Ammonium
Muscarinic Antagonist
|
|
Definition
Ipratropium
Tiotropium
Methscopolamine
|
|
|
Term
|
Definition
- used in respiratory difficulty; it blocks muscarinic receptors (Quaternary Ammonium Muscarinic Antagonist)
- can't produce relaxation of bronchial smooth muscle because the muscarinic receptors on the pulmonary tissue are non-innervated
- it's included in some respiratory preparations with beta-2 agonists, which will produce
relaxation in bronchial smooth muscle.
|
|
|
Term
Methscopolamine= scopolamine methylbromide |
|
Definition
- quaternary ammonium muscarinic receptor antagonists
- don't have any CNS effects
- produce only peripheral effects
|
|
|